Similar companies
| Company | Stocktwits Subscribers | |
|---|---|---|
 |
AmgenAMGN |
14,993 0% |
 |
Gilead SciencesGILD |
77,606 0% |
 |
Catalyst PharmaceuticalsCPRX |
15,506 0% |
 |
Inovio PharmaceuticalsINO |
92,219 0% |
 |
Anavex Life SciencesAVXL |
23,938 0% |
Cyclerion Therapeutics Stocktwits Subscriber Count
Cyclerion Therapeutics (CYCN) has 7,791 subscribers on Stocktwits, down 1.3% over the past three months. A shrinking subscriber base can signal cooling retail investor attention.
With 7,791 subscribers, Cyclerion Therapeutics has a smaller Stocktwits following than Amgen (14,993) and Gilead Sciences (77,606).
Unlike daily Stocktwits mentions, which spike around news and earnings, subscriber count reflects sustained, long-term interest from the retail investor community.
How CYCN’s Stocktwits Community Feeds the AI Score
Stocktwits subscriber count is a direct read on the size of the retail investor community tracking CYCN. It is not a stock price on its own, but sustained growth in subscribers can reflect building retail interest. AltIndex feeds Cyclerion Therapeutics’s Stocktwits community into the CYCN AI Score as one of 25+ alternative data signals, weighed against sentiment, Reddit activity, and fundamentals.
For daily discussion volume, see CYCN Stocktwits mentions. For other retail-community metrics, see Reddit subscribers and Reddit mentions.
Month over Month
| Sep 2026 | 7,820 | |
| Aug 2026 | 7,844 | |
| Jul 2026 | 7,881 | |
| Jun 2026 | 7,920 | |
| May 2026 | 7,984 |
Cyclerion Therapeutics Stocktwits Subscribers: Frequently Asked Questions
Cyclerion Therapeutics (CYCN) has 7,791 subscribers (8K) on Stocktwits, based on AltIndex’s tracking of the stock’s Stocktwits page.
Cyclerion Therapeutics's Stocktwits subscriber base is declining, down 1.3% over the past three months. View the trend chart above for the full history.
Stocktwits subscriber count is a proxy for the size of the retail investor community tracking a stock. Unlike daily mentions, which spike around news, subscriber growth reflects sustained interest. No single data point predicts a stock on its own, which is why AltIndex combines CYCN’s Stocktwits community with sentiment, Reddit activity, and 20+ other signals in its AI Score rather than reading any one signal in isolation.
Cyclerion Therapeutics underperforms its industry peers when it comes to Stocktwits Subscribers, ranking in the 5th percentile.
StockTwits is a social media platform designed specifically for the investing community. It enables investors and traders to share market insights, strategies, and real-time news updates. Essentially, it's a specialized network for financial market discussions, often characterized by brief, tweet-like posts.
Sign up and get more insights on Cyclerion Therapeutics.
See Cyclerion Therapeutics’s complete stocktwits subscribers history
Sign up to unlock 1-year and all-time charts for CYCN, plus 25+ alternative data signals, AI Scores, and real-time alerts.
Get Started for FREE
